1-2 of 2
Michael J. Tilby
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I and Pharmacodynamic Study of Fludarabine, Carboplatin, and Topotecan in Patients With Relapsed, Refractory, or High-Risk Acute Leukemia

Brenda W. Cooper, Gareth J. Veal, Tomas Radivoyevitch, Michael J. Tilby, Howard J. Meyerson, Hillard M. Lazarus, Omer N. Koc, Richard J. Creger, Graham Pearson, Geoff M. Nowell, David Gosky, Stephen T. Ingalls, Charles L. Hoppel, Stanton L. Gerson
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (20): 6830–6839.
https://doi.org/10.1158/1078-0432.CCR-04-0097
Published: 22 October 2004
View article titled, A Phase I and Pharmacodynamic Study of Fludarabine, Carboplatin, and Topotecan in Patients With Relapsed, Refractory, or High-Risk Acute Leukemia
Open the PDF for A Phase I and Pharmacodynamic Study of Fludarabine, Carboplatin, and Topotecan in Patients With Relapsed, Refractory, or High-Risk Acute Leukemia in another window
Journal Articles

Influence of Cellular Factors and Pharmacokinetics on the Formation of Platinum-DNA Adducts in Leukocytes of Children Receiving Cisplatin Therapy

Gareth J. Veal, Cinara Dias, Lisa Price, Annie Parry, Julie Errington, Juliet Hale, Andrew D. J. Pearson, Alan V. Boddy, David R. Newell, Michael J. Tilby
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (8): 2205–2212.
Published: 01 August 2001
View article titled, Influence of Cellular Factors and Pharmacokinetics on the Formation of Platinum-DNA Adducts in Leukocytes of Children Receiving Cisplatin Therapy
Open the PDF for Influence of Cellular Factors and Pharmacokinetics on the Formation of Platinum-DNA Adducts in Leukocytes of Children Receiving Cisplatin Therapy in another window